Jazz Provides Portfolio Update – Analyst Blog

By | January 15, 2013

Jazz Pharmaceuticals plc ( JAZZ ) recently discussed its product portfolio and pipeline. Key products in the company’s portfolio include Xyrem, Erwinaze and Prialt.

View original post here:
Jazz Provides Portfolio Update – Analyst Blog